O'Loughlin Steve
SEC insider (Form 3/4/5 filer). CIK 0001615840. Chief Financial Officer at CNS Pharmaceuticals, Inc. (CNSP) and 1 other issuer. 10 reported Form 4/5 transactions since Sep 2024; latest on Mar 2, 2026. Located in HOUSTON, TX.
Companies O'Loughlin Steve has filed insider reports for
- CNS Pharmaceuticals, Inc. (CNSP): Officer, Chief Financial Officer
- Actinium Pharmaceuticals, Inc. (ATNM): Officer, Chief Financial Officer
O'Loughlin Steve
CIK: 0001615840
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Mar 2, 2026CNSP
CNS Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
9.5K shares- - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
1.7K shares- - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
3.3K shares- - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
8.8K shares- - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
13.3K shares- - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
3.3K shares- - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
107.5K shares- - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
256.4K shares- - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
253.1K shares- - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
59.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 2, 2026 |  CNSP CNS Pharmaceuticals, Inc. | Award Restricted Stock Units | 9,500 | - | - | Direct |
| Mar 31, 2025 |  ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 1,666 | - | - | Direct |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 3,333 | - | - | Direct |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 8,833 | - | - | Direct |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 13,333 | - | - | Direct |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 3,333 | - | - | Direct |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 107,463 | - | - | Direct |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 256,438 | - | - | Direct |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 253,123 | - | - | Direct |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 59,066 | - | - | Direct |
1-10 of 10 transactions